Polypoidal choroidal vasculopathy—characteristics and response to treatment with bevacizumab in caucasian patients
Abstract Purpose To investigate the features and treatment response in Caucasian patients with polypoidal choroidal vasculopathy (PCV), initially treated with bevacizumab. Methods 45 eyes of 43 treatment-naïve patients with PCV were included in this retrospective study, all uniformly initially treat...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | International Journal of Retina and Vitreous |
Online Access: | https://doi.org/10.1186/s40942-022-00432-x |